Severe chronic idiopathic thrombocytopenic purpura during childhood: Definition, management, and prognosis

被引:0
|
作者
Buchanan, GR
Journeycake, JM
Adix, L
机构
[1] Univ Texas, SW Med Ctr, Div Hematol Oncol, Dept Pediat, Dallas, TX 75390 USA
[2] Childrens Med Ctr, Ctr Canc & Blood Disorders, Dallas, TX 75235 USA
来源
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2003年 / 29卷 / 06期
关键词
ITP; thrombocytopenia; chronic; severe; splenectomy; INTRAVENOUS IMMUNOGLOBULIN; DEXAMETHASONE THERAPY; IMMUNE GLOBULIN; PLATELET COUNT; CHILDREN; SPLENECTOMY; ADULTS; MULTICENTER; PREDNISONE; HEMORRHAGE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic idiopathic thrombocytopenic purpura (ITP) can be categorized as mild, moderately severe, or severe. Severe chronic ITP during childhood is a rare disorder characterized by clinically significant mucocutaneous hemorrhage, usually in the setting of marked thrombocytopenia. It can cause substantial morbidity and rarely mortality Many patients improve with time or even fully recover, but for those whose quality of life is negatively influenced by hemorrhage or side effects of conventional therapy (corticosteroids, intravenous immunoglobulin G, or anti-D), splenectomy is recommended. If splenectomy is unsuccessful or not feasible, other drug treatments are available, but few efficacy data exist, and the toxicity and cost of these treatments can be appreciable. Their use is best avoided outside of clinical trials conducted in specialty centers or in multi-institutional networks.
引用
收藏
页码:595 / 603
页数:9
相关论文
共 50 条
  • [31] Childhood chronic immune thrombocytopenic purpura (ITP)
    Blanchette, V
    BLOOD REVIEWS, 2002, 16 (01) : 23 - 26
  • [32] Safety and Efficacy of Romiplostim in Patients with Severe, Chronic Idiopathic Thrombocytopenic Purpura
    Meyer, Oliver
    Salama, Abdulgabar
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2012, 4 : 75 - 83
  • [33] ANTIPLATELET ANTIBODIES IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
    OZSOYLU, S
    KARABENT, A
    IRKEN, G
    TUNCER, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 36 (02) : 82 - 85
  • [34] Idiopathic thrombocytopenic purpura: Pathophysiology and management
    Ahn, YS
    Horstman, LL
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 123 - 131
  • [35] Idiopathic thrombocytopenic purpura: Pathophysiology and management
    Yeon S. Ahn
    Lawrence L Horstman
    International Journal of Hematology, 2002, 76 : 123 - 131
  • [36] TPO receptor agonist for chronic idiopathic thrombocytopenic purpura
    Zeng, Yan
    Duan, Xin
    Xu, Jiajun
    Ni, Xun
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [37] CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA - INCIDENCE, TREATMENT, AND OUTCOME
    REID, MM
    ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 72 (02) : 125 - 128
  • [38] Surgical treatments of chronic idiopathic thrombocytopenic purpura and prognostic factors for splenectomy
    Shino, Y
    Takahashi, N
    Okamoto, T
    Ishii, Y
    Yanagisawa, A
    Inagaki, Y
    Aoki, T
    INTERNATIONAL SURGERY, 1996, 81 (02) : 140 - 143
  • [39] Idiopathic thrombocytopenic purpura: Diagnosis and management
    George, JN
    Raskob, GE
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 316 (02): : 87 - 93
  • [40] Long-term outcome of chronic idiopathic thrombocytopenic purpura in children
    Jayabose, S
    Levendoglu-Tugal, O
    Ozkaynkak, MF
    Visintainer, P
    Sandoval, C
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (11) : 724 - 726